市值 更改
Agenus USD 3.19B 3.06B 2026-08
Amgen USD 209.65B 14.21B 2026-08
Anika Therapeutics USD 139M 3M 2025-12
Arrowhead Research USD 10.84B 664M 2026-08
AstraZeneca USD 178.16B 111.83B 2026-08
BioMarin Pharmaceutical USD 11.71B 651M 2026-08
Bristol-Myers Squibb USD 117.66B 6.17B 2026-06
Celldex Therapeutics USD 2.76B 161M 2026-08
Eli Lilly USD 1.11T 18.32B 2026-08
Halozyme Therapeutics USD 10.91B 1.63B 2026-08
Heron Therapeutics USD 238M 7M 2025-12
Ionis Pharmaceuticals USD 13.1B 642M 2026-06
Karyopharm Therapeutics USD 221M 95M 2026-08
Ligand Pharmaceuticals USD 5.31B 1.02B 2026-08
MacroGenics USD 184M 82M 2026-03
Neurocrine Biosciences USD 16.95B 3.7B 2026-06
Pfizer USD 153.17B 14.73B 2026-08
Regeneron Pharmaceuticals USD 65.37B 16.31B 2026-06
Ultragenyx Pharmaceutical USD 2.12B 1.16B 2026-08
Veracyte USD 4.69B 2.12B 2026-06